KENTA YAMAMOTO
Papers
1
Total Citations
3
H-Index
1
About
Dr. Kenta Yamamoto is a leading interventional radiologist whose work centers on advancing transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). His primary research focus is the optimization of embolic agents, particularly through the innovative use of a porous glass membrane-pumping emulsification device (GMD). Dr. Yamamoto’s major contribution lies in demonstrating that GMD can produce a high-percentage water-in-oil emulsion with exceptionally homogeneous and stable droplets, directly addressing a key limitation of conventional TACE. This breakthrough promises to enhance the locoregional therapeutic effects of the procedure, potentially improving tumor necrosis and patient outcomes. His seminal 2022 paper on this technique, which has already garnered 3 citations, serves as a foundational proof-of-concept for a new generation of more precise and effective chemoembolization. By bridging materials science and clinical application, Dr. Yamamoto is not only refining a standard treatment but also setting the stage for future trials that could redefine the standard of care for solitary HCC. His work represents a critical step toward personalized, high-precision interventional oncology.
Research Focus
Key Achievements
Top Papers
- 1